Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach.
biosensor
catalytic residue
molecular dynamics
molecular mechanism
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
pubmed:
7
11
2019
medline:
19
3
2020
entrez:
7
11
2019
Statut:
ppublish
Résumé
Coronaviruses (CoVs) infect humans and multiple other animal species, causing highly prevalent and severe diseases. 3C-like proteases (3CL
Identifiants
pubmed: 31690127
doi: 10.1096/fj.201901624RR
doi:
Substances chimiques
Viral Proteins
0
Cysteine Endopeptidases
EC 3.4.22.-
3C Viral Proteases
EC 3.4.22.28
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14575-14587Références
Pereira, H. (1989) Coronaviridae. Andrewes' Viruses of Vertebrates, 5th ed. pp. 42-57, Bailliere Tindall, London
Holmes, K. V., and Lai, M. M. C. (1996) Coronaviridae: the viruses and their replication. Virology 1, 1075-1093
Peiris, J. S., Yuen, K. Y., Osterhaus, A. D., and Stöhr, K. (2003) The severe acute respiratory syndrome. N. Engl. J. Med. 349, 2431-2441
Memish, Z. A., Mishra, N., Olival, K. J., Fagbo, S. F., Kapoor, V., Epstein, J. H., Alhakeem, R., Durosinloun, A., Al Asmari, M., Islam, A., Kapoor, A., Briese, T., Daszak, P., Al Rabeeah, A. A., and Lipkin, W. I. (2013) Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 19, 1819-1823
De Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A., Galiano, M., Gorbalenya, A. E., Memish, Z. A., Perlman, S., Poon, L. L., Snijder, E. J., Stephens, G. M., Woo, P. C., Zaki, A. M., Zambon, M., and Ziebuhr, J. (2013) Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J. Virol. 87, 7790-7792
Wood, E. N. (1977) An apparently new syndrome of porcine epidemic diarrhoea. Vet. Rec. 100, 243-244
Sun, R.-Q., Cai, R.-J., Chen, Y.-Q., Liang, P.-S., Chen, D.-K., and Song, C.-X. (2012) Outbreak of porcine epidemic diarrhea in suckling piglets, China. Emerg. Infect. Dis. 18, 161-163
Liu, C., Tang, J., Ma, Y., Liang, X., Yang, Y., Peng, G., Qi, Q., Jiang, S., Li, J., Du, L., and Li, F. (2015) Receptor usage and cell entry of porcine epidemic diarrhea coronavirus. J. Virol. 89, 6121-6125
Song, D., and Park, B. (2012) Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. Virus Genes 44, 167-175
Kweon, C.-H., Kwon, B.-J., Lee, J.-G., Kwon, G.-O., and Kang, Y.-B. (1999) Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate. Vaccine 17, 2546-2553
Perlman, S., and Netland, J. (2009) Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 7, 439-450
Zhu, X., Wang, D., Zhou, J., Pan, T., Chen, J., Yang, Y., Lv, M., Ye, X., Peng, G., Fang, L., and Xiao, S. (2017) Porcine deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving STAT2. J. Virol. 91, e00003-17
Wang, D., Fang, L., Shi, Y., Zhang, H., Gao, L., Peng, G., Chen, H., Li, K., and Xiao, S. (2015) Porcine epidemic diarrhea virus 3C-like protease regulates its interferon antagonism by cleaving NEMO. J. Virol. 90, 2090-2101
Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., Hilgenfeld, R., Yuen, K. Y., Wong, L., Gao, G., Chen, S., Chen, Z., Ma, D., Bartlam, M., and Rao, Z. (2005) Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 3, e324; erratum: e428
Deeks, S. G., Smith, M., Holodniy, M., and Kahn, J. O. (1997) HIV-1 protease inhibitors. A review for clinicians. JAMA 277, 145-153
Lamarre, D., Anderson, P. C., Bailey, M., Beaulieu, P., Bolger, G., Bonneau, P., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., Faucher, A. M., Goudreau, N., Kawai, S. H., Kukolj, G., Lagacé, L., La Plante, S. R., Narjes, H., Poupart, M. A., Rancourt, J., Sentjens, R. E., St George, R., Simoneau, B., Steinmann, G., Thibeault, D., Tsantrizos, Y. S., Weldon, S. M., Yong, C. L., and Llinàs-Brunet, M. (2003) An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426, 186-189; erratum: 246
Wu, C.-Y., Jan, J.-T., Ma, S.-H., Kuo, C.-J., Juan, H.-F., Cheng, Y.-S. E., Hsu, H.-H., Huang, H.-C., Wu, D., Brik, A., Liang, F. S., Liu, R. S., Fang, J. M., Chen, S. T., Liang, P. H., and Wong, C. H. (2004) Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc. Natl. Acad. Sci. USA 101, 10012-10017
Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., and Freire, E. (2004) Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. Biochemistry 43, 4906-4912
Blanchard, J. E., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D., and Brown, E. D. (2004) High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem. Biol. 11, 1445-1453
Jain, R. P., Pettersson, H. I., Zhang, J., Aull, K. D., Fortin, P. D., Huitema, C., Eltis, L. D., Parrish, J. C., James, M. N., Wishart, D. S., and Vederas, J. C. (2004) Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro. J. Med. Chem. 47, 6113-6116
Kao, R. Y., Tsui, W. H., Lee, T. S., Tanner, J. A., Watt, R. M., Huang, J.-D., Hu, L., Chen, G., Chen, Z., Zhang, L., He, T., Chan, K. H., Tse, H., To, A. P., Ng, L. W., Wong, B. C., Tsoi, H. W., Yang, D., Ho, D. D., and Yuen, K. Y. (2004) Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics. Chem. Biol. 11, 1293-1299
Tanner, J. A., Zheng, B.-J., Zhou, J., Watt, R. M., Jiang, J.-Q., Wong, K.-L., Lin, Y.-P., Lu, L.-Y., He, M.-L., Kung, H.-F., Kesel, A. J., and Huang, J. D. (2005) The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem. Biol. 12, 303-311
Ragland, D. A., Nalivaika, E. A., Nalam, M. N., Prachanronarong, K. L., Cao, H., Bandaranayake, R. M., Cai, Y., Kurt-Yilmaz, N., and Schiffer, C. A. (2014) Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease. J. Am. Chem. Soc. 136, 11956-11963
Matthew, A. N., Zephyr, J., Hill, C. J., Jahangir, M., Newton, A., Petropoulos, C. J., Huang, W., Kurt-Yilmaz, N., Schiffer, C. A., and Ali, A. (2017) Hepatitis C virus NS3/4A protease inhibitors incorporating flexible P2 quinoxalines target drug resistant viral variants. J. Med. Chem. 60, 5699-5716
Ozen, A., Sherman, W., and Schiffer, C. A. (2013) Improving the resistance profile of hepatitis C NS3/4A inhibitors: dynamic substrate envelope guided design. J. Chem. Theory Comput. 9, 5693-5705
Soumana, D. I., Kurt Yilmaz, N., Ali, A., Prachanronarong, K. L., and Schiffer, C. A. (2016) Molecular and dynamic mechanism underlying drug resistance in genotype 3 hepatitis C NS3/4A protease. J. Am. Chem. Soc. 138, 11850-11859
Matthew, A. N., Leidner, F., Newton, A., Petropoulos, C. J., Huang, W., Ali, A., Kurt Yilmaz, N., and Schiffer, C. A. (2018) Molecular mechanism of resistance in a clinically significant double-mutant variant of HCV NS3/4A protease. Structure 26, 1360-1372.e5
Soumana, D. I., Kurt Yilmaz, N., Prachanronarong, K. L., Aydin, C., Ali, A., and Schiffer, C. A. (2016) Structural and thermodynamic effects of macrocyclization in HCV NS3/4A inhibitor MK-5172. ACS Chem. Biol. 11, 900-909
Galbán, S., Jeon, Y. H., Bowman, B. M., Stevenson, J., Sebolt, K. A., Sharkey, L. M., Lafferty, M., Hoff, B. A., Butler, B. L., Wigdal, S. S., Binkowski, B. F., Otto, P., Zimmerman, K., Vidugiris, G., Encell, L. P., Fan, F., Wood, K. V., Galbán, C. J., Ross, B. D., and Rehemtulla, A. (2013) Imaging proteolytic activity in live cells and animal models. PLoS One 8, e66248
Kilianski, A., Mielech, A. M., Deng, X., and Baker, S. C. (2013) Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J. Virol. 87, 11955-11962
Shyu, Y. J., Liu, H., Deng, X., and Hu, C. D. (2006) Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques 40, 61-66
Wigdal, S. S., Anderson, J. L., Vidugiris, G. J., Shultz, J., Wood, K. V., and Fan, F. (2008) A novel bioluminescent protease assay using engineered firefly luciferase. Curr. Chem. Genomics 2, 16-28
Zhou, J., Wang, D., Xi, Y., Zhu, X., Yang, Y., Lv, M., Luo, C., Chen, J., Ye, X., Fang, L., and Xiao, S. (2017) Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor. Biochem. Biophys. Res. Commun. 488, 621-627
Cheng, S.-C., Chang, G.-G., and Chou, C.-Y. (2010) Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirus main protease. Biophys. J. 98, 1327-1336
Anand, K., Yang, H., Bartlam, M., Rao, Z., and Hilgenfeld, R. (2005) Coronavirus main proteinase: target for antiviral drug therapy. In Coronaviruses With Special Emphasis on First Insights Concerning SARS, pp. 173-199, Springer, Berlin, Germany.
Shi, J., Wei, Z., and Song, J. (2004) Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors. J. Biol. Chem. 279, 24765-24773
Case, D. A., Betz, R. M., Cerutti, D. S., Cheatham, T. E. III, Darden, T. A., Duke, R. E., Giese, T. J., Gohlke, H., Goetz, A. W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T. S., Le Grand, S., Li, P., Luchko, T., Luo, R., Madej, B., Merz, K. M., Monard, G., Needham, P., Nguyen, H., Nguyen, H. T., Omelyan, I., Onufriev, A., Roe, D. R., Roitberg, A., Salomon-Ferrer, R., Simmerling, C. L., Smith, W., Swails, J., Walker, R. C., Wang, J., Wolf, R. M., Wu, X., York, D. M., and Kollman, P. A. (2015) AMBER 2015. University of California, San Francisco
Case, D. A., Cheatham, T. E. III, Darden, T., Gohlke, H., Luo, R., Merz, K. M., Jr., Onufriev, A., Simmerling, C., Wang, B., and Woods, R. J. (2005) The Amber biomolecular simulation programs. J. Comput. Chem. 26, 1668-1688
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., and Klein, M. L. (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., and Schulten, K. (2005) Scalable molecular dynamics with NAMD. J. Comput. Chem. 26, 1781-1802
Ryckaert, J.-P., Ciccotti, G., and Berendsen, H. J. (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327-341
Izaguirre, J. A., Catarello, D. P., Wozniak, J. M., and Skeel, R. D. (2001) Langevin stabilization of molecular dynamics. J. Chem. Phys. 114, 2090-2098
Darden, T., York, D., and Pedersen, L. (1993) Particle mesh Ewald: an N · log (N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089-10092
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., and Pedersen, L. G. (1995) A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577-8593
Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular dynamics. J. Mol. Graph. 14, 33-38, 27-28
Ichiye, T., and Karplus, M. (1991) Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations. Proteins 11, 205-217
Iwai, H., and Plückthun, A. (1999) Circular β-lactamase: stability enhancement by cyclizing the backbone. FEBS Lett. 459, 166-172
Zettler, J., Schütz, V., and Mootz, H. D. (2009) The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett. 583, 909-914
Hegyi, A., and Ziebuhr, J. (2002) Conservation of substrate specificities among coronavirus main proteases. J. Gen. Virol. 83, 595-599
Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J., and Hilgenfeld, R. (2002) Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α-helical domain. EMBO J. 21, 3213-3224
Thiel, V., Ivanov, K. A., Putics, A., Hertzig, T., Schelle, B., Bayer, S., Weissbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., and Ziebuhr, J. (2003) Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84, 2305-2315
Colell, E. A., Iserte, J. A., Simonetti, F. L., and Marino-Buslje, C. (2018) MISTIC2: comprehensive server to study coevolution in protein families. Nucleic Acids Res. 46, W323-W328
Ye, G., Deng, F., Shen, Z., Luo, R., Zhao, L., Xiao, S., Fu, Z. F., and Peng, G. (2016) Structural basis for the dimerization and substrate recognition specificity of porcine epidemic diarrhea virus 3C-like protease. Virology 494, 225-235
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., and Hilgenfeld, R. (2003) Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300, 1763-1767
Ali, A., Aydin, C., Gildemeister, R., Romano, K. P., Cao, H., Özen, A., Soumana, D., Newton, A., Petropoulos, C. J., Huang, W., and Schiffer, C. A. (2013) Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3/4A protease inhibitors to drug resistance. ACS Chem. Biol. 8, 1469-1478
Romano, K. P., Ali, A., Royer, W. E., and Schiffer, C. A. (2010) Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. Proc. Natl. Acad. Sci. USA 107, 20986-20991
Romano, K. P., Laine, J. M., Deveau, L. M., Cao, H., Massi, F., and Schiffer, C. A. (2011) Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease. J. Virol. 85, 6106-6116
Kozakov, D., Grove, L. E., Hall, D. R., Bohnuud, T., Mottarella, S. E., Luo, L., Xia, B., Beglov, D., and Vajda, S. (2015) The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat. Protoc. 10 733-755
Brown, E. G. Liu, H. Kit, L.C. Baird, S., and Nesrallah, M. (2001) Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 98, 6883-6888
Lai, M., and Holmes K. (2001) Coronaviridae: The viruses and their replication. In Fields Virology (Knipe D.M., and Howley, P. M., eds.) Lippincott Philadelphia
Kim, Y., Lovell S., Tiew, K.-C., Mandadapu, S. R., Alliston, K. R., Battaile, K. P., Groutas, W. C., and Chang, K.-O. (2012) Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J. Virol. 86, 11754-11762